Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Alcohol consumption is inversely associated with stage 3 chronic kidney disease in middle-aged Taiwanese men

Authors: Yueh-Han Hsu, Hsiang-Chu Pai, Yao-Mao Chang, Wen-Hsin Liu, Chih-Cheng Hsu

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is a major global public health burden, but there is limited understanding of the relationship of alcohol consumption with CKD.

Methods

In this cross-sectional multivariable study, all participants of a health check-up program in Ditmanson Medical Foundation Chia-Yi Christian Hospital in Taiwan from 2003 to 2009 (15 353 women and 11 900 men) were included for analysis. Estimated glomerular filtration rate was used to define CKD stage and history of alcohol consumption was obtained by self-reporting. Multivariable logistic regression analyses of gender-specific association of alcohol drinking with stage 3 CKD were conducted. A trend tests was conducted to check the dose–response relationship of alcohol consumption with renal disease. A sensitivity test was conducted to rule out the likelihood of reverse causality.

Results

The prevalence of stage 3 CKD was lower in drinkers than non-drinkers (p < 0.001) and the percentage of drinkers with stage 3 CKD was less than that of non-drinkers. Multivariable analysis indicated that alcohol consumption was negatively associated with the presence of stage 3 CKD in men (adjusted odds ratio [aOR] for occasional drinking: 0.68, 95% CI: 0.59 ~ 0.78, p < 0.001; aOR for frequent drinking: 0.47, 95% CI: 0.35 ~ 0.63, p < 0.001). Advanced age, hypertension, anemia, BMI of at least 24, hyperuricemia, and proteinuria were also associated with stage 3 CKD in men. Trend tests indicated lower odds of having stage 3 CKD with increased alcohol consumption in both genders. Subgroup analyses and sensitivity tests also indicated the reverse association between alcohol consumption and stage 3 CKD in men regardless of age, diabetes status, and other risky behaviors.

Conclusions

Alcohol consumption was inversely associated with stage 3 CKD in Taiwanese men. However, considering the potential of other health damage with alcohol consumption, the current results should be interpreted cautiously.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298: 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298: 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed
2.
go back to reference Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC: Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003, 14: S131-S138. 10.1097/01.ASN.0000070152.11927.4A.CrossRefPubMed Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC: Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003, 14: S131-S138. 10.1097/01.ASN.0000070152.11927.4A.CrossRefPubMed
3.
go back to reference Hsu CC, Hwang SJ, Wen CP, Chang HY, Chen T, Shiu RS, Horng SS, Chang YK, Yang WC: High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006, 48: 727-738. 10.1053/j.ajkd.2006.07.018.CrossRefPubMed Hsu CC, Hwang SJ, Wen CP, Chang HY, Chen T, Shiu RS, Horng SS, Chang YK, Yang WC: High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006, 48: 727-738. 10.1053/j.ajkd.2006.07.018.CrossRefPubMed
5.
go back to reference Wu MJ, Shu KH, Liu PH, Chiang PH, Cheng CH, Chen CH, Yu DM, Chuang YW: High risk of renal failure in stage 3B chronic kidney disease is under-recognized in standard medical screening. J Chin Med Assoc. 2010, 73: 515-522. 10.1016/S1726-4901(10)70113-1.CrossRefPubMed Wu MJ, Shu KH, Liu PH, Chiang PH, Cheng CH, Chen CH, Yu DM, Chuang YW: High risk of renal failure in stage 3B chronic kidney disease is under-recognized in standard medical screening. J Chin Med Assoc. 2010, 73: 515-522. 10.1016/S1726-4901(10)70113-1.CrossRefPubMed
6.
go back to reference Tanaka K, Hara S, Kushiyama A, Ubara Y, Yoshida Y, Mizuiri S, Aikawa A, Kawatzu S: Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol. 2011, 15: 391-397. 10.1007/s10157-011-0420-6.CrossRefPubMed Tanaka K, Hara S, Kushiyama A, Ubara Y, Yoshida Y, Mizuiri S, Aikawa A, Kawatzu S: Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol. 2011, 15: 391-397. 10.1007/s10157-011-0420-6.CrossRefPubMed
7.
go back to reference Ito S, Naritomi H, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res. 2012, 35: 867-873. 10.1038/hr.2012.59.CrossRefPubMedPubMedCentral Ito S, Naritomi H, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res. 2012, 35: 867-873. 10.1038/hr.2012.59.CrossRefPubMedPubMedCentral
8.
go back to reference Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004, 164: 659-663. 10.1001/archinte.164.6.659.CrossRefPubMed Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004, 164: 659-663. 10.1001/archinte.164.6.659.CrossRefPubMed
9.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056/NEJMoa041031.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056/NEJMoa041031.CrossRefPubMed
10.
go back to reference WHO: Global status report on alcohol and health 2011. 2011, Geneva: World Health Organization, 37-41. WHO: Global status report on alcohol and health 2011. 2011, Geneva: World Health Organization, 37-41.
11.
go back to reference Perneger TV, Whelton PK, Puddey IB, Klag MJ: Risk of end-stage renal disease associated with alcohol consumption. Am J Epidemiol. 1999, 150: 1275-1281. 10.1093/oxfordjournals.aje.a009958.CrossRefPubMed Perneger TV, Whelton PK, Puddey IB, Klag MJ: Risk of end-stage renal disease associated with alcohol consumption. Am J Epidemiol. 1999, 150: 1275-1281. 10.1093/oxfordjournals.aje.a009958.CrossRefPubMed
12.
go back to reference Shankar A, Klein R, Klein BE: The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006, 164: 263-271. 10.1093/aje/kwj173.CrossRefPubMed Shankar A, Klein R, Klein BE: The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006, 164: 263-271. 10.1093/aje/kwj173.CrossRefPubMed
13.
go back to reference White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ: Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009, 24: 2464-2472. 10.1093/ndt/gfp114.CrossRefPubMed White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ: Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009, 24: 2464-2472. 10.1093/ndt/gfp114.CrossRefPubMed
14.
go back to reference Savdie E, Grosslight GM, Adena MA: Relation of alcohol and cigarette consumption to blood pressure and serum creatinine levels. J Chronic Dis. 1984, 37: 617-623. 10.1016/0021-9681(84)90111-5.CrossRefPubMed Savdie E, Grosslight GM, Adena MA: Relation of alcohol and cigarette consumption to blood pressure and serum creatinine levels. J Chronic Dis. 1984, 37: 617-623. 10.1016/0021-9681(84)90111-5.CrossRefPubMed
15.
go back to reference Cueto-Manzano AM, Martinez-Ramirez HR, Cortes-Sanabria L: Management of chronic kidney disease: primary health-care setting, self-care and multidisciplinary approach. Clin Nephrol. 2010, 74: 99-104. Cueto-Manzano AM, Martinez-Ramirez HR, Cortes-Sanabria L: Management of chronic kidney disease: primary health-care setting, self-care and multidisciplinary approach. Clin Nephrol. 2010, 74: 99-104.
16.
go back to reference Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM: Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med. 2005, 165: 1048-1053. 10.1001/archinte.165.9.1048.CrossRefPubMed Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM: Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med. 2005, 165: 1048-1053. 10.1001/archinte.165.9.1048.CrossRefPubMed
17.
go back to reference Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, Chen CS, Wu X, Hamm LL, He J: Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008, 73: 870-876. 10.1038/sj.ki.5002774.CrossRefPubMed Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, Chen CS, Wu X, Hamm LL, He J: Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008, 73: 870-876. 10.1038/sj.ki.5002774.CrossRefPubMed
18.
go back to reference Gupta PC, Ray CS: Epidemiology of betel quid usage. Ann Acad Med Singapore. 2004, 33: 31-36.PubMed Gupta PC, Ray CS: Epidemiology of betel quid usage. Ann Acad Med Singapore. 2004, 33: 31-36.PubMed
19.
go back to reference Chen JW, Shaw JH: A study on betel quid chewing behavior among Kaohsiung residents aged 15 years and above. J Oral Pathol Med: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 1996, 25: 140-143. 10.1111/j.1600-0714.1996.tb00209.x.CrossRef Chen JW, Shaw JH: A study on betel quid chewing behavior among Kaohsiung residents aged 15 years and above. J Oral Pathol Med: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 1996, 25: 140-143. 10.1111/j.1600-0714.1996.tb00209.x.CrossRef
20.
go back to reference Hsu YH, Liu WH, Chen W, Kuo YC, Hsiao CY, Hung PH, Jong IC, Chiang PC, Hsu CC: Association of betel nut chewing with chronic kidney disease: a retrospective 7-year study in Taiwan. Nephrology (Carlton). 2011, 16: 751-757. 10.1111/j.1440-1797.2011.01489.x.CrossRef Hsu YH, Liu WH, Chen W, Kuo YC, Hsiao CY, Hung PH, Jong IC, Chiang PC, Hsu CC: Association of betel nut chewing with chronic kidney disease: a retrospective 7-year study in Taiwan. Nephrology (Carlton). 2011, 16: 751-757. 10.1111/j.1440-1797.2011.01489.x.CrossRef
21.
go back to reference Liu WH, Hsu CC, Hsu YH: Chewing areca nut as an independent risk factor for proteinuria in middle-aged men. Kaohsiung J Med Sci. 2013, 29: 214-220. 10.1016/j.kjms.2012.08.037.CrossRefPubMed Liu WH, Hsu CC, Hsu YH: Chewing areca nut as an independent risk factor for proteinuria in middle-aged men. Kaohsiung J Med Sci. 2013, 29: 214-220. 10.1016/j.kjms.2012.08.037.CrossRefPubMed
22.
go back to reference National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39: S1-S266. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39: S1-S266.
23.
go back to reference Wortmann RL, Kelley WN: Gout and hyperuricemia. Textbook of Rheumatology. Edited by: Kelley WN, Harris ED, Ruddy S, Sledge CB. 2005, Philadelphia: W.B. Saunders, 1402-1448. 7 Wortmann RL, Kelley WN: Gout and hyperuricemia. Textbook of Rheumatology. Edited by: Kelley WN, Harris ED, Ruddy S, Sledge CB. 2005, Philadelphia: W.B. Saunders, 1402-1448. 7
24.
go back to reference Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007, 71: 159-166. 10.1038/sj.ki.5002017.CrossRefPubMed Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007, 71: 159-166. 10.1038/sj.ki.5002017.CrossRefPubMed
25.
go back to reference Rodrigo R, Rivera G, Orellana M, Araya J, Bosco C: Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Life Sci. 2002, 71: 2881-2895. 10.1016/S0024-3205(02)02140-9.CrossRefPubMed Rodrigo R, Rivera G, Orellana M, Araya J, Bosco C: Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Life Sci. 2002, 71: 2881-2895. 10.1016/S0024-3205(02)02140-9.CrossRefPubMed
26.
go back to reference Orellana M, Valdes E, Fernandez J, Rodrigo R: Effects of chronic ethanol consumption on extramitochondrial fatty acid oxidation and ethanol metabolism by rat kidney. Gen Pharmacol. 1998, 30: 719-723. 10.1016/S0306-3623(97)00342-X.CrossRefPubMed Orellana M, Valdes E, Fernandez J, Rodrigo R: Effects of chronic ethanol consumption on extramitochondrial fatty acid oxidation and ethanol metabolism by rat kidney. Gen Pharmacol. 1998, 30: 719-723. 10.1016/S0306-3623(97)00342-X.CrossRefPubMed
27.
go back to reference Dreosti IE, Manuel SJ, Buckley RA: Superoxide dismutase (EC 1.15.1.1), manganese and the effect of ethanol in adult and foetal rats. Br J Nutr. 1982, 48: 205-210. 10.1079/BJN19820106.CrossRefPubMed Dreosti IE, Manuel SJ, Buckley RA: Superoxide dismutase (EC 1.15.1.1), manganese and the effect of ethanol in adult and foetal rats. Br J Nutr. 1982, 48: 205-210. 10.1079/BJN19820106.CrossRefPubMed
28.
go back to reference Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AA, Panichi V, Filippi C, Bertelli A: Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol. 2001, 37: 262-270. 10.1097/00005344-200103000-00004.CrossRefPubMed Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AA, Panichi V, Filippi C, Bertelli A: Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol. 2001, 37: 262-270. 10.1097/00005344-200103000-00004.CrossRefPubMed
29.
go back to reference Kahraman A, Erkasap N, Serteser M, Koken T: Protective effect of quercetin on renal ischemia/reperfusion injury in rats. J Nephrol. 2003, 16: 219-224.PubMed Kahraman A, Erkasap N, Serteser M, Koken T: Protective effect of quercetin on renal ischemia/reperfusion injury in rats. J Nephrol. 2003, 16: 219-224.PubMed
30.
go back to reference Burchfiel CM, Tracy RE, Chyou PH, Strong JP: Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu heart program. Arterioscler Thromb Vasc Biol. 1997, 17: 760-768. 10.1161/01.ATV.17.4.760.CrossRefPubMed Burchfiel CM, Tracy RE, Chyou PH, Strong JP: Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu heart program. Arterioscler Thromb Vasc Biol. 1997, 17: 760-768. 10.1161/01.ATV.17.4.760.CrossRefPubMed
31.
go back to reference Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, Sakata T, Korthuis RJ: Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med. 2003, 34: 810-817. 10.1016/S0891-5849(02)01430-2.CrossRefPubMed Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, Sakata T, Korthuis RJ: Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med. 2003, 34: 810-817. 10.1016/S0891-5849(02)01430-2.CrossRefPubMed
32.
go back to reference Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH: Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993, 329: 1829-1834. 10.1056/NEJM199312163292501.CrossRefPubMed Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH: Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993, 329: 1829-1834. 10.1056/NEJM199312163292501.CrossRefPubMed
33.
go back to reference Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH: Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994, 272: 929-933. 10.1001/jama.1994.03520120039028.CrossRefPubMed Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH: Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994, 272: 929-933. 10.1001/jama.1994.03520120039028.CrossRefPubMed
34.
go back to reference Wakabayashi I, Kobaba-Wakabayashi R, Masuda H: Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. Diabetes Care. 2002, 25: 1223-1228. 10.2337/diacare.25.7.1223.CrossRefPubMed Wakabayashi I, Kobaba-Wakabayashi R, Masuda H: Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. Diabetes Care. 2002, 25: 1223-1228. 10.2337/diacare.25.7.1223.CrossRefPubMed
35.
go back to reference Northcote J, Livingston M: Accuracy of self-reported drinking: observational verification of ‘last occasion’ drink estimates of young adults. Alcohol Alcohol. 2011, 46: 709-713. 10.1093/alcalc/agr138.CrossRefPubMed Northcote J, Livingston M: Accuracy of self-reported drinking: observational verification of ‘last occasion’ drink estimates of young adults. Alcohol Alcohol. 2011, 46: 709-713. 10.1093/alcalc/agr138.CrossRefPubMed
36.
go back to reference Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, Willett WC: The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991, 133: 810-817.PubMed Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, Willett WC: The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991, 133: 810-817.PubMed
37.
go back to reference Parekh RS, Klag MJ: Alcohol: role in the development of hypertension and end-stage renal disease. Curr Opin Nephrol Hypertens. 2001, 10: 385-390. 10.1097/00041552-200105000-00014.CrossRefPubMed Parekh RS, Klag MJ: Alcohol: role in the development of hypertension and end-stage renal disease. Curr Opin Nephrol Hypertens. 2001, 10: 385-390. 10.1097/00041552-200105000-00014.CrossRefPubMed
38.
go back to reference Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP, Lash JP, McGill JB, Mitch WE, Remuzzi G, et al: Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol. 2006, 1: 761-767. 10.2215/CJN.01381005.CrossRefPubMed Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP, Lash JP, McGill JB, Mitch WE, Remuzzi G, et al: Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol. 2006, 1: 761-767. 10.2215/CJN.01381005.CrossRefPubMed
39.
go back to reference Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD: Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004, 66: 1131-1138. 10.1111/j.1523-1755.2004.00863.x.CrossRefPubMed Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD: Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004, 66: 1131-1138. 10.1111/j.1523-1755.2004.00863.x.CrossRefPubMed
40.
go back to reference See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH: Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clinical rheumatology. 2011, 30: 323-330. 10.1007/s10067-010-1461-z.CrossRefPubMed See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH: Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clinical rheumatology. 2011, 30: 323-330. 10.1007/s10067-010-1461-z.CrossRefPubMed
41.
go back to reference Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, et al: The 2010 Canadian hypertension education program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol. 2010, 26: 249-258. 10.1016/S0828-282X(10)70379-2.CrossRefPubMedPubMedCentral Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, et al: The 2010 Canadian hypertension education program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol. 2010, 26: 249-258. 10.1016/S0828-282X(10)70379-2.CrossRefPubMedPubMedCentral
Metadata
Title
Alcohol consumption is inversely associated with stage 3 chronic kidney disease in middle-aged Taiwanese men
Authors
Yueh-Han Hsu
Hsiang-Chu Pai
Yao-Mao Chang
Wen-Hsin Liu
Chih-Cheng Hsu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-254

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.